We show that targeting intracellular PD-L1 with cell-penetrating antibodies against either mouse or human PD-L1 effectively reduces ovarian tumor PD-L1, leading to tumor-cell growth inhibition and increased apoptosis both in vitro and in vivo. The gene discussed is CD274; the disease is ovarian neoplasm.